Continuum Advisory »

Seres Therapeutics shares owned by Continuum Advisory

Quarter-by-quarter ownership of Seres Therapeutics (MCRB) shares owned by Continuum Advisory from 13F filings

Historical chart of Continuum Advisory investment in Seres Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Seres Therapeutics held by Continuum Advisory consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Seres Therapeutics by Continuum Advisory

Quarter filed Position value Share count Share price at filing
2024-03-31 $984 955 1.03

More positions owned by Continuum Advisory

Capital Group Dividend Value Etf Etf (CGDV)
Apple Stock (AAPL)
Jpmorgan Core Plus Bond Etf Jpmorgan Core Plus Bond Fund Etf (JCPB)
Microsoft Corp Stock (MSFT)
Vanguard Extended Market Etf Etf (VXF)
Vanguard Total Stock Market Etf Etf (VTI)
Ishares 20 Year Treasury Bond Etf Etf (TLT)
Invesco Qqq Trust Series I Etf (QQQ)
Amazon Stock (AMZN)
Vanguard Total Bond Market Etf Etf (BND)
Barnes Group Stock (B)
Spdr Msci Usa Strategicfactors Etf Etf (QUS)
Vanguard Large-cap Etf Etf (VV)
Ishares S&p 100 Etf Etf (OEF)
Ishares Core S&p 500 Etf Etf (IVV)

View all positions for Continuum Advisory

Top funds holding Seres Therapeutics

Flagship Ventures Management
FMR
BlackRock
Vanguard Group
Hudson Bay Capital Management
Geode Capital Management
Woodline Partners
Bank of America Corporation
Handelsbanken Fonder AB
Goldman Sachs Group
Millennium Management
Susquehanna International
Tang Capital Management
Northern Trust
Charles Schwab Investment Management

View all funds holding Seres Therapeutics